Petros Pharmaceuticals (PTPI) Stock Chart & Stock Price History $0.03 0.00 (-1.79%) As of 08/22/2025 03:54 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Petros Pharmaceuticals Stock Price Performance The Petros Pharmaceuticals (PTPI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.68%, with a year-to-date return of -99.72%. In the past month, the stock has decreased 8.03%, reflecting recent market activity. As of the latest close, Petros Pharmaceuticals traded at $0.03 with a market cap of $857 thousand and volume of 260,246 shares. Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.78%1 Month Performance-8.03%3 Month Performance-29.49%Year-To-Date Performance-99.72%1 Year Performance-99.68% PTPI Stock Chart for Sunday, August, 24, 2025 PTPI Chart by TradingView Petros Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$0.03$0.03-4.51%$0.03$0.03260,246 shs$857,000.0008/21/2025$0.03$0.03-2.37%$0.03$0.0373,527 shs$897,000.0008/20/2025$0.03$0.03$0.03$0.03749,675 shs$919,000.0008/19/2025$0.03$0.03+2.43%$0.03$0.03176,916 shs$919,000.0008/18/2025$0.03$0.03-5.88%$0.03$0.0388,245 shs$897,000.0008/15/2025$0.03$0.03-1.29%$0.03$0.03744,992 shs$953,000.0008/14/2025$0.03$0.03+6.53%$0.03$0.03225,912 shs$966,000.0008/13/2025$0.03$0.03-3.00%$0.03$0.03431,100 shs$907,000.0008/12/2025$0.03$0.03+6.76%$0.03$0.03108,839 shs$935,000.0008/11/2025$0.03$0.03+3.69%$0.03$0.03268,394 shs$876,000.00 Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$0.03$0.03-4.24%$0.03$0.03909,932 shs$844,000.0008/07/2025$0.03$0.03+4.81%$0.03$0.03260,610 shs$882,000.0008/06/2025$0.03$0.03-8.16%$0.03$0.03811,915 shs$841,000.0008/05/2025$0.03$0.03-7.55%$0.03$0.03163,803 shs$916,000.0008/04/2025$0.03$0.03-1.85%$0.03$0.03262,626 shs$991,000.0008/01/2025$0.03$0.03+7.28%$0.03$0.03686,942 shs$1.01 million07/31/2025$0.03$0.03+9.82%$0.03$0.03862,821 shs$941,000.0007/30/2025$0.03$0.03-4.84%$0.03$0.03138,373 shs$857,000.0007/29/2025$0.03$0.03-3.99%$0.03$0.03323,602 shs$901,000.0007/28/2025$0.03$0.03-2.90%$0.03$0.03483,085 shs$938,000.0007/25/2025$0.03$0.03+3.68%$0.03$0.03361,189 shs$966,000.0007/24/2025$0.03$0.03+1.01%$0.03$0.031.40 million shs$932,000.0007/23/2025$0.03$0.03+8.82%$0.03$0.03120,717 shs$922,000.00 Related Companies Redhill Biopharma Stock Chart Virax Biolabs Group Stock Chart CERo Therapeutics Stock Chart Qualigen Therapeutics Stock Chart BioVie Stock Chart PMGC Stock Chart Enveric Biosciences Stock Chart PowerUp Acquisition Stock Chart CNS Pharmaceuticals Stock Chart Lipella Pharmaceuticals Stock Chart Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTPI) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access